Mission Statement, Vision, & Core Values (2025) of Haleon plc.

An Overview of Haleon plc

General Overview of Haleon plc

Haleon plc, established as a standalone company in July 2022, emerged from GlaxoSmithKline's consumer healthcare division. It specializes in consumer health products encompassing pain relief, oral health, respiratory health, and vitamins, minerals & supplements. Notable brands include Sensodyne, Voltaren, and Panadol. As of 2024, Haleon reported sales of approximately £10 billion, reflecting its robust market presence and diverse product portfolio.

Financial Performance in the Latest Reporting Period

In its latest financial report for the fiscal year 2023, Haleon achieved a record-breaking revenue of £10.3 billion, indicating a year-over-year growth of 9.6%. The company saw significant contributions from its leading product categories:

This performance was driven by strong sales in emerging markets, which grew by 15%, while mature markets reported a solid growth rate of 7%. Haleon's strategic focus on innovation and portfolio expansion has paid off significantly, with its R&D investments totaling £500 million in 2023.

Introduction to Haleon as an Industry Leader

Haleon stands as a leading player in the consumer healthcare sector, underscoring its commitment to improving everyday health. With a market capitalization of approximately £30 billion in 2024, the company’s strong financial metrics and strategic positioning highlight its ability to respond effectively to consumer needs. The organization fosters an innovative environment, aiming to increase the efficiency of its supply chain and enhance customer engagement. For those interested in understanding the full scope of Haleon's success and strategic initiatives, further details are available below.

Mission Statement of Haleon plc

Mission Statement of Haleon plc

Haleon plc's mission statement reflects its dedication to improving health and well-being for consumers around the globe. The company's mission is to deliver innovative, science-backed solutions in consumer health, focusing on quality and accessibility. This mission guides Haleon's long-term goals and drives its business strategies.

Core Component 1: Commitment to Health and Well-being

The first core component of Haleon's mission emphasizes its commitment to health and well-being. This aspect is crucial as it aligns with the global trend towards personal health management. In 2023, the global consumer health market was valued at approximately $144 billion and is projected to reach $216 billion by 2028, reflecting a compound annual growth rate (CAGR) of 8.5%.

Haleon actively participates in this growing market, offering products designed to enhance everyday health. For instance, its leading pain relief brand, Sensodyne, captured a market share of approximately 9.5% in the sensitive toothpaste segment in 2022.

Core Component 2: Innovation and Quality

The second key component revolves around innovation and quality. Haleon invests significantly in research and development to create effective, high-quality products. In 2022, Haleon allocated approximately $200 million to R&D, contributing to the launch of several new products, including an enhanced version of its pain relief brand, Advil, which saw a 15% increase in sales year-over-year.

According to a recent survey, over 78% of consumers reported that product innovation was a significant factor in their purchasing decisions related to health products. This highlights Haleon's focus on innovation as an essential driver of customer loyalty and market growth.

Core Component 3: Accessibility and Consumer Focus

The third component of Haleon’s mission statement addresses accessibility and consumer focus. Haleon strives to ensure that its products are available to a diverse range of consumers worldwide. As of 2023, Haleon's products are sold in more than 100 countries, with distribution networks established to reach underserved markets.

Moreover, Haleon aims to make its products affordable. The company reported that 65% of its product range is priced below the average market price, making healthcare more accessible to consumers. The company’s initiative to provide free health consultations in select regions has also led to an increase in brand trust, with customer satisfaction ratings improving by 12% since the program's inception.

Vision Statement of Haleon plc

Vision Statement Overview

The vision statement of Haleon plc emphasizes a commitment to consumer health. This aim is reflected in their strategic focus to deliver innovative consumer healthcare products. The company seeks to be recognized globally as a leader in consumer health, helping individuals lead healthier, happier lives.

Global Reach and Market Position

In 2022, Haleon recorded revenue of £10.4 billion, with significant growth projected through 2024, targeting an increase of approximately 4% to 6% annually. Their product portfolio, which includes iconic brands like Sensodyne and Panadol, positions them strongly in both developed and emerging markets.

Commitment to Innovation

Haleon's vision includes a focus on innovation, with investment plans of about £500 million for the development of new products in the next two years. The company aims to launch at least 10 new products annually, reinforcing their commitment to meet evolving consumer needs in health and wellness.

Sustainability Goals

Aligning with broader corporate responsibility, Haleon’s vision incorporates sustainability. By 2025, they aim to achieve 100% recyclable or reusable packaging. Additionally, they plan to reduce greenhouse gas emissions by 50% across their value chain, showcasing their dedication to social and environmental impact.

Consumer Engagement and Accessibility

Haleon envisions enhancing consumer engagement by leveraging digital health platforms. By 2024, the company aims to increase user interaction by 30% through mobile applications and online resources, making health information more accessible to consumers globally.

Health and Wellness Focus

Haleon's vision reflects a strong focus on health and wellness. The company aims to be the first choice for consumers seeking healthcare solutions, with a target to increase market penetration by 15% in key therapeutic areas by 2024. This strategy underscores their dedication to addressing unmet health needs.

Employee Engagement and Corporate Culture

Haleon recognizes the importance of a motivated workforce in achieving its vision. They plan to enhance employee engagement levels to 80% by 2024 through initiatives aimed at fostering an inclusive and innovative corporate culture.

Core Values of Haleon plc

Customer Care

Haleon plc emphasizes the value of customer care by prioritizing the needs and well-being of its consumers. This commitment is reflected in various initiatives aimed at enhancing customer satisfaction and ensuring product safety.

In 2023, Haleon's product portfolio, which includes brands like Sensodyne and Panadol, generated revenues of approximately £10 billion. The company has implemented rigorous consumer feedback programs, receiving over 500,000 customer interactions annually, aimed at continuous improvement and innovation.

The establishment of the Haleon Customer Experience Center in 2022 further demonstrates their dedication, providing real-time insights into customer behavior and preferences. This center has helped increase customer satisfaction scores by 15% in the last year.

Integrity

Integrity is a cornerstone of Haleon's operational philosophy, guiding their ethical standards and accountability in business practices. The company adheres strictly to compliance regulations and ethical norms, ensuring transparent communication with stakeholders.

In 2023, Haleon reported a 100% compliance rate in its internal audits, emphasizing its commitment to ethical practices. Additionally, the company conducted over 200 training sessions on compliance and ethics for employees globally, reinforcing the importance of integrity in everyday operations.

Haleon's approach is further evidenced by its adherence to the UN Global Compact principles, where they have been recognized for promoting anti-corruption measures, leading to a 30% reduction in compliance-related incidents from the previous year.

Innovation

Innovation at Haleon is driven by a focus on research and development, aimed at bringing new products to market that meet evolving consumer needs. The company allocates a significant portion of its revenue to R&D.

In 2023, Haleon invested approximately £1.5 billion in R&D, representing about 15% of its total revenue. This investment has resulted in the launch of over 20 new products, including advancements in oral health and pain relief formulations.

The company also adopted a collaborative approach by partnering with academic institutions, resulting in approximately 10% of new product innovations originating from external collaborations in the past year.

Respect

Respect forms an integral part of Haleon's corporate culture, underpinning interactions with employees, customers, and communities. The company actively seeks to foster an inclusive and diverse workplace.

In 2023, Haleon achieved a workforce diversity rating of 45% for women in leadership roles. The company runs several initiatives, including mentorship programs for underrepresented groups, impacting over 2,000 employees worldwide.

Haleon also engages in community outreach programs that have benefited over 1 million people, focusing on health education and wellness, thus demonstrating respect for its wider community.

Teamwork

Teamwork at Haleon is essential for driving collaborative efforts across all levels of the organization. The company fosters an environment where teamwork is encouraged and celebrated.

In 2023, Haleon launched a global employee collaboration platform, which has been utilized by over 75% of its workforce. This initiative has improved inter-departmental communication and project efficiency, leading to a 20% increase in project completion rates.

The company's annual Teamwork Awards highlight outstanding collaborative achievements, with more than 100 teams recognized for their contributions in 2023, enhancing motivation and engagement across the workforce.